Pharmaceutical companies are working on ways to evade copay accumulator

In an effort to coax patients away from expensive drugs, pharmacy benefits managers (PBMs) have introduced a new “copay accumulator” approach for its corporate customers. The programs prevent copay card funds from counting toward a patient’s required out-of-pocket spending before insurance kicks in on expensive specialty drugs. However, major pharmaceutical companies are working on new payment options to evade detection by the PBMs so that a patient still benefits from the financial aid. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.